

You have been doing everything right. Counting calories, cutting carbs, exercising when you can. Maybe you lost weight once, even twice, only to watch it come back. Each time feels more frustrating than the last.
Nothing is wrong with you. Weight regain after dieting isn't a personal failure. It's a biological response, and GLP-1 medications in Singapore are designed to address it. Your body adjusts its hunger hormones to fight against weight loss, making it harder to sustain results through willpower alone. Getting the right GLP-1 dosing is what makes the difference between effective treatment and wasted effort.
GLP-1 receptor agonists work with your body's own hormone system to reduce appetite, quiet food noise, and support lasting weight loss. But GLP-1 in Singapore isn't one-size-fits-all. Getting the dose right matters, and that is what this article covers. You will learn about semaglutide dosing schedules (for Ozempic, Wegovy, and Rybelsus), tirzepatide dosing (Mounjaro), who qualifies for treatment in Singapore, what to expect during titration, and how doctors adjust doses based on your individual response.
Before discussing specific dosing protocols, it helps to understand who can access these medications in Singapore.
Singapore uses adjusted BMI thresholds for Asian populations, recognising that health risks increase at lower BMI levels compared to Western populations. The Ministry of Health (MOH) Clinical Practice Guidelines set these pharmacotherapy thresholds:
To put those numbers in perspective, for a woman who is 160 cm tall, a BMI of 27.5 works out to around 70 kg.
At Trimly, our doctors use slightly broader eligibility criteria. You may qualify with a BMI of 24 or higher if you have weight-related conditions (such as PCOS, diabetes, or hypertension), or a BMI of 27.5 or higher without additional conditions. This allows us to help more patients who are genuinely struggling, while still following responsible medical practice.
GLP-1 medications are prescription-only in Singapore. Before starting treatment, your doctor will review your medical history and check for contraindications. These include a personal or family history of medullary thyroid carcinoma (a rare type of thyroid cancer accounting for only 3-4% of cases), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), active pancreatitis, or severe gallbladder disease.
If you are pregnant or planning to become pregnant, GLP-1 medications aren't recommended. Semaglutide should be discontinued at least two months before a planned pregnancy.
You can read more about what doctors check before prescribing GLP-1.
Semaglutide in Singapore is the most widely prescribed GLP-1 medication, available in both injectable and oral forms. Each formulation follows a different dosing schedule, and understanding the differences helps you know what to expect.
Wegovy is specifically approved for weight management and follows a 16-week titration schedule before reaching the maintenance dose. The "start low, go slow" approach helps your body adjust gradually and reduces the likelihood of side effects like nausea.
| Week | Dose | Purpose |
|---|---|---|
| 1-4 | 0.25 mg weekly | Initial tolerability phase |
| 5-8 | 0.5 mg weekly | First dose increase |
| 9-12 | 1.0 mg weekly | Second dose increase |
| 13-16 | 1.7 mg weekly | Third dose increase |
| 17+ | 2.4 mg weekly | Maintenance dose |
In the STEP 1 trial, patients taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks. That is roughly 13-14 kg for someone starting at 90 kg. About 86.4% of participants lost more than 5% of their body weight, and 50.5% lost more than 15%.
The STEP 5 trial showed these results hold over longer periods, with participants maintaining an average weight loss of 15.2% at 104 weeks (two years).
Ozempic uses the same active ingredient as Wegovy (semaglutide) but is approved primarily for type 2 diabetes management. Some doctors in Singapore prescribe it off-label for weight loss at adjusted doses.
The standard Ozempic dosing schedule:
Because Ozempic's maximum dose (2.0 mg) is lower than Wegovy's maintenance dose (2.4 mg), the weight loss results may differ. However, for patients with type 2 diabetes, the STEP 2 trial demonstrated 9.6% weight loss with semaglutide over 68 weeks.
Rybelsus is the oral form of semaglutide, taken as a daily tablet. It is a good option if you prefer not to use injections.
The dosing schedule for Rybelsus:
There are specific instructions for taking Rybelsus. You need to swallow the tablet on an empty stomach first thing in the morning with no more than 120 ml of plain water. Then wait at least 30 minutes before eating, drinking anything else, or taking other medications. These steps matter because food and larger amounts of water can reduce how well the medication is absorbed.
The current 14 mg dose of Rybelsus produces modest weight loss of approximately 3-5% in clinical trials (the PIONEER trials studied patients with type 2 diabetes). Newer higher-dose oral formulations are in development, with the 50 mg dose showing 15.1% weight loss at 68 weeks in the OASIS 1 trial, approaching the results seen with injectable semaglutide.
For a detailed comparison of formats, see our guide on oral vs injectable GLP-1 options.
Interested in semaglutide dosing that is tailored to your body and goals?
Book ConsultationTirzepatide (sold as Mounjaro and Zepbound) is a newer medication that works on two hormone receptors instead of one. It targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, which is why it is sometimes called a "twincretin."
Tirzepatide uses a gradual dose escalation over several months:
| Week | Dose | Notes |
|---|---|---|
| 1-4 | 2.5 mg weekly | Starting dose |
| 5-8 | 5 mg weekly | First therapeutic dose |
| 9-12 | 7.5 mg weekly | Gradual increase |
| 13-16 | 10 mg weekly | Continued titration |
| 17-20 | 12.5 mg weekly | Continued titration |
| 21+ | 15 mg weekly | Maximum dose |
Doses increase by 2.5 mg every four weeks, with available dose strengths of 2.5, 5, 7.5, 10, 12.5, and 15 mg.
The SURMOUNT-1 trial produced some of the strongest weight loss results ever seen with medication. At the 15 mg dose over 72 weeks:
For comparison, the placebo group lost only 3.1%. These results were in patients with obesity who did not have type 2 diabetes.
Beyond weight loss, SURMOUNT-1 also showed improvements in metabolic health: triglycerides reduced by 20-25%, systolic blood pressure dropped by approximately 6-8 mmHg, and diastolic blood pressure dropped by about 4.2 mmHg.
You might wonder why GLP-1 medications can't simply be started at the full dose. The gradual approach isn't arbitrary. It serves two purposes.
The most common side effects of GLP-1 medications are gastrointestinal: nausea, bloating, constipation, and occasionally diarrhoea. These symptoms are most likely to occur when you first start taking the medication or when your dose increases.
By starting at a low dose and increasing every four weeks, your body has time to adjust. Most patients find that side effects are mild and improve within the first few weeks at each new dose level. Over 10% of users report nausea initially, but this typically settles as the body acclimates.
To manage side effects during titration:
Not everyone needs the maximum dose, and that's okay. Some patients see excellent results at a moderate dose with minimal side effects. Others may need the full maintenance dose for optimal weight loss. Your doctor will assess your response at each step and decide whether to increase, hold steady, or occasionally step back a dose.
This is one reason why GLP-1 treatment monitoring is so valuable. Regular check-ins allow your doctor to adjust your dosing plan based on how your body actually responds, not just a standard protocol.
While the titration schedules above provide a general framework, your doctor will personalise your dosing based on several factors.
If you experience persistent nausea or vomiting at a particular dose, your doctor may slow the titration pace. Instead of increasing every four weeks, they might hold you at the current dose for an extra two to four weeks before trying the next step up. In some cases, a temporary dose reduction helps.
If you miss several consecutive doses, your doctor may recommend restarting at a lower dose rather than picking up where you left off. This precaution prevents a sudden return of side effects.
Patients with type 2 diabetes who are also taking insulin or sulfonylureas may need adjustments to their diabetes medications when starting GLP-1 treatment, to avoid the risk of hypoglycaemia (low blood sugar).
Kidney or liver conditions also require careful dose monitoring, as severe gastrointestinal side effects can lead to dehydration, which may in rare cases affect kidney function. Your doctor will track metabolic markers, including blood pressure, fasting glucose, HbA1c, and lipid levels, throughout your treatment.
Doctors look at the overall trend, not just individual weigh-ins. If you are losing weight steadily at a moderate dose with good tolerability, there may be no need to push to the maximum dose. On the other hand, if weight loss has stalled and you are tolerating the current dose well, increasing may be appropriate.
At Trimly, our doctors provide unlimited free follow-ups to track your progress and adjust your treatment plan as needed. This ongoing support is included in the all-in pricing of $350-650/month.
Setting realistic expectations helps you stay motivated and recognise progress when it happens.
| Medication | Average Weight Loss | Timeframe | Trial |
|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | 14.9% | 68 weeks | STEP 1 |
| Mounjaro (tirzepatide 15 mg) | 20.9-22.5% | 72 weeks | SURMOUNT-1 |
| Saxenda (liraglutide 3.0 mg) | 8.0% | 56 weeks | SCALE Obesity |
| Rybelsus (oral semaglutide 14 mg) | ~3-5% | Varies | PIONEER trials |
Patients with type 2 diabetes typically see slightly lower weight loss. In the STEP 2 trial, patients with diabetes lost 9.6% of their body weight with semaglutide over 68 weeks.
Most patients begin to notice reduced appetite within the first two to four weeks, even at the starting dose. Visible weight loss usually becomes apparent after four to six weeks, with many patients reaching a 5% weight reduction by months four to six. A 10-15% reduction is typically achieved within seven to 12 months, depending on the medication and dose.
GLP-1 medications work best as part of a long-term treatment plan that includes balanced nutrition, regular physical activity, and healthy sleep habits. Obesity is now recognised as a chronic condition, and these medications address the underlying biology.
The STEP 4 trial showed that participants who continued semaglutide maintained significantly more weight loss compared to those who switched to placebo after an initial treatment period. Patients who discontinued regained an average of 6.9% of their body weight. This doesn't mean you must take medication forever, but it does mean that building sustainable habits during treatment is essential for keeping the weight off.
Here are some practical details that make day-to-day treatment easier.
Transparency around pricing helps you plan and make an informed decision.
At Trimly, GLP-1 treatment costs between $350 and $650 per month, depending on the medication type and dose. This is an all-in price that includes your doctor consultation, the medication itself, home delivery, and unlimited follow-up consultations. There are no hidden fees for dose adjustments, check-ins, or WhatsApp support with your doctor.
GLP-1 medications prescribed for weight loss are generally not covered by Medisave or standard health insurance in Singapore. However, if semaglutide (Ozempic) is prescribed for type 2 diabetes alongside weight management and your BMI is 27.5 or higher, partial coverage may apply. It is worth checking with your insurer, as coverage rules are evolving.
Ready to find out if GLP-1 treatment is right for you?
Book ConsultationFor Wegovy (semaglutide), the standard titration takes 16 weeks to reach the maintenance dose of 2.4 mg weekly. For Mounjaro (tirzepatide), reaching the maximum 15 mg dose takes approximately 20 weeks. Rybelsus (oral semaglutide) reaches its maintenance dose of 14 mg by month three. Your doctor may adjust these timelines based on how you tolerate each increase.
Yes. If you are experiencing good weight loss and minimal side effects at a lower dose, your doctor may recommend staying there rather than pushing to the maximum. The goal is to find the dose that gives you the best balance of effectiveness and tolerability.
Your doctor can slow down the titration, holding you at the current dose for longer before increasing. In some cases, they may temporarily lower your dose and try the increase again later. Eating smaller meals, staying hydrated, and avoiding rich or spicy foods can also help manage nausea during this period.
Yes. Patients with type 2 diabetes may need adjustments to their existing diabetes medications (like insulin or sulfonylureas) when starting GLP-1 treatment, to prevent hypoglycaemia. The GLP-1 dosing schedule itself follows a similar titration pattern, but your doctor will monitor blood glucose levels more closely.
This depends on your medical history, BMI, any existing conditions, and your preferences (such as whether you would rather take a daily tablet or a weekly injection). A doctor consultation is the best way to determine the right medication and starting dose for your specific situation. At Trimly, our MOH-licensed doctors assess all of these factors during your initial video consultation.
GLP-1 dosing isn't something to guess at. The difference between effective treatment and unnecessary side effects often comes down to proper titration, regular monitoring, and dose adjustments tailored to your body.
Here is what to remember:
If you have been struggling with weight despite your best efforts, GLP-1 treatment in Singapore offers a science-backed option that works with your biology. The right dosing plan, guided by a doctor who monitors your progress, can make the difference.
At Trimly, our MOH-licensed doctors provide personalised GLP-1 treatment plans with transparent pricing ($350-650/month), unlimited follow-ups, and home delivery of your medication. Book a consultation to find out which GLP-1 dosing plan is right for you.